Evidence map›Paper›PMID 26610890›Full record

ArticleGlycobiology2016

Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.

Leslie Revoredo, Shengjun Wang, Eric Paul Bennett, Henrik Clausen, Kelley W Moremen, Donald L Jarvis, Kelly G Ten Hagen, Lawrence A Tabak, Thomas A Gerken

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Altered O-glycosylation of βThe FEBS journal · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. In vivo models of mucin biosynthesis and function.Advanced drug delivery reviews · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Leslie RevoredoDepartment of Chemistry.
Shengjun WangCopenhagen Center for Glycomics (CCG), Departments of Cellular and Molecular Medicine and Dentistry, Faculty of Health Sciences, University of Copenhagen, Copenhagen N DK-2200, Denmark.
Eric Paul BennettCopenhagen Center for Glycomics (CCG), Departments of Cellular and Molecular Medicine and Dentistry, Faculty of Health Sciences, University of Copenhagen, Copenhagen N DK-2200, Denmark.
Henrik ClausenCopenhagen Center for Glycomics (CCG), Departments of Cellular and Molecular Medicine and Dentistry, Faculty of Health Sciences, University of Copenhagen, Copenhagen N DK-2200, Denmark.
Kelley W MoremenComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.
Donald L JarvisDepartment of Molecular Biology, University of Wyoming, Laramie, WY 82071, USA.
Kelly G Ten HagenDevelopmental Glycobiology Section.
Lawrence A TabakSection on Biological Chemistry, Department of Health and Human Services, NIDCR, National Institutes of Health, Bethesda, MD 20892, USA.
Thomas A GerkenDepartment of Chemistry Department of Pediatrics and Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA txg2@cwru.edu.
University of Copenhagen · DKCase Western Reserve University · USInstitute of Developmental Physiology · RUNational Institutes of Health · USUniversity of Georgia · USUniversity of Wyoming · US

Funding

Role of O-glycosylation in Animal DevelopmentZIADE000713 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI TEN HAGEN, KELLY G · 2009 to 2025
$30.6M
ZINC DEFICIENCY &PROTEIN EXPRESSION IN RAT OLFACTORY BULBSP41RR005351 · NCRR · UNIVERSITY OF GEORGIA (UGA) · PI VENOT, ANDRE · 1989 to 2011
$18.4M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Structure and Function of UDP-GalNAc:polypeptide alpha-GalNAc transferasesZIADE000739 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI TABAK, LAWRENCE A. · 2012 to 2025
$12.9M
Recombinant Production of Glycosylation Enzymes for Biochem/Structural StudiesP01GM107012 · NIGMS · UNIVERSITY OF GEORGIA · PI PRESTEGARD, JAMES H. · 2013 to 2017
$7.5M
MUCIN SITE SPECIFIC O-GLYCOSYLATIONR01CA078834 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GERKEN, THOMAS A · 1999 to 2012
$3.4M
Initiation and Regulation of Mucin-Type O-GlycosylationR01GM113534 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI GERKEN, THOMAS A · 2018 to 2023
$1.6M
Initiation and regulation of mucin-type O-glycosylationU01GM113534 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI GERKEN, THOMAS A · 2015 to 2017
$1.0M
NCI NIH HHS R01-CA78834NCRR NIH HHS P41 RR005351NCRR NIH HHS P41-RR005351NIGMS NIH HHS P01 GM107012NIGMS NIH HHS P01-GM107012NIGMS NIH HHS P41 GM103390NIGMS NIH HHS P41-GM103390NIGMS NIH HHS R01 GM113534NIGMS NIH HHS U01 GM113534NIGMS NIH HHS U01-GM113534
6 · The paper itself

Abstract

A large family of UDP-GalNAc:polypeptide GalNAc transferases (ppGalNAc-Ts) initiates and defines sites of mucin-type Ser/Thr-O-GalNAc glycosylation. Family members have been classified into peptide- and glycopeptide-preferring subfamilies, although both families possess variable activities against glycopeptide substrates. All but one isoform contains a C-terminal carbohydrate-binding lectin domain whose roles in modulating glycopeptide specificity is just being understood. We have previously shown for several peptide-preferring isoforms that the presence of a remote Thr-O-GalNAc, 6-17 residues from a Ser/Thr acceptor site, may enhance overall catalytic activity in an N- or C-terminal direction. This enhancement varies with isoform and is attributed to Thr-O-GalNAc interactions at the lectin domain. We now report on the glycopeptide substrate utilization of a series of glycopeptide (human-ppGalNAc-T4, T7, T10, T12 and fly PGANT7) and peptide-preferring transferases (T2, T3 and T5) by exploiting a series of random glycopeptide substrates designed to probe the functions of their catalytic and lectin domains. Glycosylation was observed at the -3, -1 and +1 residues relative to a neighboring Thr-O-GalNAc, depending on isoform, which we attribute to specific Thr-O-GalNAc binding at the catalytic domain. Additionally, these glycopeptide-preferring isoforms show remote lectin domain-assisted Thr-O-GalNAc enhancements that vary from modest to none. We conclude that the glycopeptide specificity of the glycopeptide-preferring isoforms predominantly resides in their catalytic domain but may be further modulated by remote lectin domain interactions. These studies further demonstrate that both domains of the ppGalNAc-Ts have specialized and unique functions that work in concert to control and order mucin-type O-glycosylation.

Indexed as

Amino Acid SequenceBinding SitesCarbohydratesCatalytic DomainFucoseGlycopeptidesGlycosylationHumansLectinsMucinsPhylogenyProtein BindingProtein ConformationProtein Structure, TertiarySialyltransferasesSubstrate SpecificityCarbohydratesFucoseGlycopeptidesLectinsMucinsN-acetylfucosamineSialyltransferasesglycoprotein biosynthesisglycosyltransferaselectinmucin

Identifiers

PMID26610890
PMCPMC4767052
OpenAlexW2266458663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.